Allergies Food Intolerance
Conditions
Interventions
Group 1: Both a serum and a capillary blood sample will be collected from all subjects. Based on these samples, the sponsor decides whether the subjects will be invited for a second blood draw.
In thi
Sponsors
R-Biopharm AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. ability to understand and willingness to sign a written consent form. 2. females and males 18 years of age or older. 3. Presence of allergy(s) and/or food intolerance(s) ("self-reported"). 4. collection of the required volume of whole blood and capillary blood possible. 5. min. 50 kg body weight (in case of allergy).
Exclusion criteria
Exclusion criteria: 6. pregnant and lactating women 7. anemia 8. increased bleeding tendency, or known blood clotting disorder 9. intake of immunosuppressants 10. intake of Omalizumab 11. an event due to which, in the opinion of the principal investigator, the subject is not suitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is the recruitment of a maximum of 300 subjects with allergy and/or food intolerance. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome is finding individuals with a "rare" allergen (e.g., baker's yeast, dandelion, or cocoa). | — |
Countries
Germany
Contacts
Public ContactMichael Kramer
Praxis für Laboratoriumsmedizin
Outcome results
None listed